Status:

COMPLETED

Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

Lead Sponsor:

Mario Negri Institute for Pharmacological Research

Conditions:

Kidney Transplant

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

Abnormalities in glucidic and lipidic metabolism are common features in renal transplant patients on chronic immunossupression with steroids and calcineurin inhibitors. In kidney transplant patients w...

Detailed Description

INTRODUCTION Decreased insulin sensitivity, impaired glucose tolerance and dyslipidemia are common features in renal transplant patients on chronic immunosuppression with steroids and calcineurine inh...

Eligibility Criteria

Inclusion

  • age: 18-70 years old
  • kidney transplant since at least six months
  • serum creatinine ≤ 3mg/dl without dialysis requirement
  • serum creatinine changes ≤ + 30 % over the last three months
  • overnight urinary albumin excretion rate ≥20µg/min
  • well controlled hypertension (systolic/diastolic blood pressure \<150/90 mmHg)
  • concomitant treatment with inhibitors of the renin angiotensin system (RAS) since at least six months
  • effective contraception
  • written informed consent
  • legal capacity

Exclusion

  • acute graft rejection over the last six months
  • immunosuppressive therapy with FK506
  • evidence of previous or concomitant liver disease and abnormal liver transaminases over the last six months
  • evidence of heart failure (NYHA class II or more) or fluid overload
  • overt diabetes or concomitant treatment with oral antidiabetic agents and/or insulin
  • specific contraindication to the study drug
  • legal incapacity and/or other circumstances rendering the patient unable to understand the nature, scope and possible consequences of the study

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2007

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT00309309

Start Date

April 1 2005

End Date

July 1 2007

Last Update

July 3 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Research Center for Rare Diseases

Ranica, Bergamo, Italy, 24020